AdvanSix (ASIX) Projected to Post Quarterly Earnings on Friday

AdvanSix (NYSE:ASIX) is expected to be releasing its Q4 2025 results before the market opens on Friday, February 20th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $340.85 million for the quarter. Interested persons may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Friday, February 20, 2026 at 9:30 AM ET.

AdvanSix Stock Performance

Shares of NYSE:ASIX opened at $18.07 on Wednesday. The company has a market capitalization of $485.36 million, a price-to-earnings ratio of 9.41 and a beta of 1.72. The firm’s 50 day simple moving average is $17.33 and its 200 day simple moving average is $18.27. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.36 and a quick ratio of 0.74. AdvanSix has a fifty-two week low of $14.10 and a fifty-two week high of $31.03.

Institutional Investors Weigh In On AdvanSix

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD increased its holdings in AdvanSix by 13.4% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,821 shares of the company’s stock worth $274,000 after buying an additional 1,869 shares during the last quarter. Atom Investors LP acquired a new stake in AdvanSix in the 4th quarter valued at about $189,000. Mariner LLC lifted its stake in AdvanSix by 10.2% in the 4th quarter. Mariner LLC now owns 11,065 shares of the company’s stock valued at $191,000 after purchasing an additional 1,023 shares during the last quarter. Aigen Investment Management LP bought a new position in AdvanSix during the fourth quarter worth about $187,000. Finally, Inspire Advisors LLC acquired a new position in AdvanSix during the fourth quarter worth approximately $176,000. 86.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on ASIX. Wall Street Zen lowered shares of AdvanSix from a “hold” rating to a “sell” rating in a report on Friday, January 23rd. Weiss Ratings restated a “sell (d+)” rating on shares of AdvanSix in a research report on Monday, December 29th. Finally, Truist Financial assumed coverage on AdvanSix in a research note on Thursday, January 15th. They set a “hold” rating and a $19.00 price objective on the stock. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, AdvanSix currently has a consensus rating of “Hold” and a consensus price target of $28.67.

AdvanSix Company Profile

AdvanSix, Inc (NYSE: ASIX) is an integrated chemical manufacturer specializing in the production of nylon 6 intermediates and related co‐products. Established as a publicly traded spin‐off from Honeywell Specialty Chemicals in June 2016, the company is headquartered in Parsippany, New Jersey.

The company’s principal product is caprolactam, the key building block for nylon 6 resin, used in fibers and engineering plastics across industries. In addition to caprolactam and nylon 6 resin, AdvanSix produces ammonium sulfate fertilizer and industrial chemicals such as phenol and acetone.